1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. RECURSION PHARMACEUTICALS INC - ORDINARY SHARES - CLASS A

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

XNAS: RXRX

Weak Stock
Download real time

4.25 -0.20 (-4.49%)

65.61% Fall from 52W High

9.1M XNAS Volume

XNAS 30 May, 2025 12:02 PM (EDT)

Watchlist

Portfolio

Share
5S
18W
1O
2T
1,727.6

Market Cap

High in industry
-3

PE TTM

Negative PE TTM
0

PEG TTM

1.7

Price to Book

Below industry Median
0

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Recursion Pharmaceuticals Inc - Ordinary Shares - Class A is on 03 Jun 2025 for the purpose of Recursion Pharmaceuticals Inc Annual General Meeting for 2025 See details

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A - RXRX - stock price prediction, stock price target, analyst ratings from 8 analysts

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A has a share price target of US$ 7, revenue growth forecast of 28.9%, and profit growth estimate of -18.0% for FY25, based on top 8 analyst calls.

Forecaster Screeners